Pelay-Gimeno Marta, Albericio Fernando, Tulla-Puche Judit
Section of Organic Chemistry, Department of Inorganic and Organic Chemistry, University of Barcelona, Barcelona, Spain.
Networking Centre on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, Spain.
Nat Protoc. 2016 Oct;11(10):1924-1947. doi: 10.1038/nprot.2016.116. Epub 2016 Sep 15.
Cyclodepsipeptides are cyclic peptides in which at least one amide link on the backbone is replaced with an ester link. These natural products present a high structural diversity that corresponds to a broad range of biological activities. Therefore, they are very promising pharmaceutical candidates. Most of the cyclodepsipeptides have been isolated from marine organisms, but they can also originate from terrestrial sources. Within the family of cyclodepsipeptides, 'head-to-side-chain' cyclodepsipeptides have, in addition to the macrocyclic core closed by the ester bond, an arm terminated with a polyketide moiety or a branched amino acid, which makes their synthesis a challenge. This protocol provides guidelines for the synthesis of 'head-to-side-chain cyclodepsipeptides' and includes-as an example-a detailed procedure for preparing pipecolidepsin A. Pipecolidepsin was chosen because it is a very complex 'head-to-side-chain cyclodepsipeptide' of marine origin that shows cytotoxicity in several human cancer cell lines. The procedure begins with the synthesis of the noncommercial protected amino acids (2R,3R,4R)-2-{[(9H-fluoren-9-yl)methoxy]carbonylamino}-3-hydroxy-4,5-dimethylhexanoic acid (Fmoc-AHDMHA-OH), Alloc-pipecolic-OH, (4R,5R)-5-((((9H-fluoren-9-yl)methoxy)carbonylamino)-4-oxo-4-(tritylamino)butyl)-2,2-dimethyl-1,3-dioxolane-4-carboxylic acid (Fmoc-DADHOHA(acetonide, Trt))-OH and the pseudodipeptide (2R,3R,4R)-3-hydroxy-2,4,6-trimethylheptanoic acid ((HTMHA)-D-Asp(OtBu)-OH). It details the assembly of the depsipeptidic skeleton using a fully solid-phase approach (typically on an amino polystyrene resin coupled to 3-(4-hydroxymethylphenoxy)propionic acid (AB linker)), including the key ester formation step. It concludes by describing the macrocyclization step performed on solid phase, and the global deprotection and cleavage of the cyclodepsipeptide from the resin using a trifluoroacetic acid-HO-triisopropylsilane (TFA-HO-TIS; 95:2.5:2.5) cocktail, as well as the final purification by semipreparative HPLC. The entire procedure takes ∼2 months to complete.
环缩肽是一类环状肽,其主链上至少有一个酰胺键被酯键取代。这些天然产物具有高度的结构多样性,对应着广泛的生物活性。因此,它们是非常有前景的药物候选物。大多数环缩肽是从海洋生物中分离出来的,但它们也可以源自陆地来源。在环缩肽家族中,“头对侧链”环缩肽除了由酯键封闭的大环核心外,还有一个以聚酮部分或支链氨基酸结尾的臂,这使得它们的合成具有挑战性。本方案提供了“头对侧链环缩肽”合成的指导方针,并以制备哌可利德菌素A的详细步骤为例。选择哌可利德菌素是因为它是一种非常复杂的海洋来源的“头对侧链环缩肽”,在几种人类癌细胞系中显示出细胞毒性。该方法首先合成非商业保护氨基酸(2R,3R,4R)-2-{[(9H-芴-9-基)甲氧基]羰基氨基}-3-羟基-4,5-二甲基己酸(Fmoc-AHDMHA-OH)、Alloc-哌可利酸-OH、(4R,5R)-5-((((9H-芴-9-基)甲氧基)羰基氨基)-4-氧代-4-(三苯甲基氨基)丁基)-2,2-二甲基-1,3-二氧戊环-4-羧酸(Fmoc-DADHOHA(丙酮化物,Trt))-OH)和假二肽(2R,3R,4R)-3-羟基-2,4,6-三甲基庚酸((HTMHA)-D-天冬氨酸(OtBu)-OH)。它详细描述了使用完全固相方法(通常在与3-(4-羟甲基苯氧基)丙酸(AB接头)偶联的氨基聚苯乙烯树脂上)组装缩肽骨架,包括关键的酯形成步骤。它通过描述在固相上进行的大环化步骤、使用三氟乙酸-HO-三异丙基硅烷(TFA-HO-TIS;95:2.5:2.5)混合液对环缩肽进行整体脱保护和从树脂上裂解,以及通过半制备HPLC进行最终纯化来结束。整个过程大约需要2个月完成。